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What personality traits found in a 2-year-old can be recognized in that 
same person at age 25? A unique BUSM study, which follows the psy-
chological development of about 30 individuals, promises to provide 
interesting answers to this question. See story on page 3. 
This scanning eiectron micrograph shows an experimental vein graft that has been injured at the 
time of implantation. Twenty-four hours later, numerous platelets can be seen attached to the 
damaged wall of the graft. (Photo by William Quist) 
Scientists at BUSM seek to prevent 
'delayed failures' in bypass surgery 
Of the many forms of surgery per-
formed today, few have the image of 
risk and boldness associated with 
blood-vessel bypass operations. 
Yet while there is clearly some risk 
involved for patients undergoing 
bypass surgery, blood-vessel grafts 
have become a relatively routine pro-
cedure for experienced surgeons, 
said Frank W. LoGerfo, M.D. Even 
the much-publicized triple bypass 
heart surgery—where grafts are used 
to replace three of the arteries that 
supply blood to the heart—has 
become a relatively safe procedure. 
"The mortality of bypass opera-
tions is very low—usually around 1 
or 2 percent," said LoGerfo, an asso-
ciate professor of surgery and direc-
tor of vascular surgery training at 
BUSM, and associate visiting sur-
geon and coordinator of the Renal 
Transplant Service at University Hos-
pital, a principal teaching hospital of 
BUSM. 
"On the other hand," he added, 
"there is a very serious problem 
associated with these operations in 
that a great many of the grafts fail 
within the first year." 
Such delayed failures occur in 20 
continued on page 5 
Researcher aims 
to determine if 
backyard pesticides 
really are 'safe' 
Toxic waste dumps and chemical 
spills are among the unfortunate 
byproducts of our technological 
world. Television and newspaper 
reports of toxic sites confront us 
daily. The frequent media coverage 
of these potential or existing chemi-
cal hazards has made toxic waste 
one of the most controversial issues 
of our time. 
But all chemical hazards do not 
come in the frightening form of bar-
rels rotting in a backlot. Far less 
obvious is the possible danger from 
toxic substances that we encounter 
through ordinary activities, hidden 
substances with effects that may 
take years to surface. Judith Mar-
quis, Ph.D., is investigating the pos-
sibility that certain "safe" pesticides 
that rid backyard vegetable or flower 
gardens—and vast acres of agricul-
tural produce—of insects ultimately 
may produce harmful effects in 
humans and animals. 
Marquis, an associate professor in 
the Department of Pharmacology 
and Experimental Therapeutics at 
Boston University School of Medi-
cine, is the principal investigator of a 
three-year $250,000 investigation of 
pesticide toxicity. She started the 
federally funded project last year. 
Marquis is examining the group of 
continued on page 2 
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Judith Marquis, Ph.D., and research assistant Charies Cyr coiiect data in their investigation of 
organophosphate pesticides. (Photo by Bradford P. Herzog) 
Pesticides... 
continued from page 1 
pesticides known as organophos-
phates: Parathion, Malathion, Azin-
phos-Methyl ("Guthion") and Diazi-
non. "These pesticides are used by 
greenhouses and home gardeners 
as well as by large-scale agricultural-
ists," said Marquis. 
While it is known that the pesti-
cides are highly toxic to organisms 
exposed to them in high concentra-
tions, little is known about the effects 
of lesser amounts, particularly on 
humans. "These pesticides are con-
sidered to be selective—that is, they 
are more lethal to insects than they 
are to people or animals," Marquis 
explained. 
According to Marquis, who cur-
rently is conducting tests on low-level 
pesticide toxicity using animal tis-
sues, the organophosphate pesti-
cides exert lethal action by affecting 
the cholinergic system, the network 
of nerves and chemicals that controls 
muscle response. The neurotransmit-
ter called acetylcholine, one of the 
chemicals that occurs naturally in the 
body and carries information from 
nerves to muscles, is an integral part 
of this system. Acetylcholine carries 
signals to skeletal muscles, control-
ling movement, and to the central 
nervous system, signaling memory 
function in the brain. It also functions 
in transmitting sensory information by 
carrying input from outside the body 
to the brain through the central ner-
vous system. 
Neurotransmitters usually are 
released by nerves in little "pack-
ages" of molecules. These molecules 
travel across a very small area of the 
nerve (a few microns long) called a 
synapse. At the other side of the 
synapse, the molecules interact with 
what are called receptor proteins, 
triggering a response in a nerve or 
muscle. 
The combination of acetylcholine 
and the receptor protein produces a 
contraction in the muscles. For 
example, when skeletal muscles con-
tract, they produce movement. Con-
traction of the diaphragm allows 
breathing to occur, and the contrac-
tion of the smooth muscle of the gut 
makes the digestive system function. 
However, muscles cannot function 
in a continuously contracted state, 
but must relax and contract to be 
effective. An enzyme called acetyl-
cholinesterase regulates this pro-
cess. Acetylcholinesterase is found 
in the postsynaptic membrane along 
with the receptor proteins, and it 
destroys the acetylcholine molecule 
after it has combined with the recep-
tor proteins. This allows the muscle 
to relax. 
According to Marquis, the organo-
phospate pesticides block the 
enzyme acetylcholinesterase by 
mimicking the actions of acetylcho-
line. By interacting with acetylcholi-
nesterase in the same way that ace-
tylcholine does, the organophos-
phates prevent the enzyme from per-
iforming its function. "Once the organ-
ophosphates bind to the enzyme, the 
enzyme is tied up," said Marquis. 
"The chemical interaction between 
the insecticide and the enzyme is 
very tight." 
According to Marquis, this process 
ultimately results in the destruction of 
the cholinergic function. She and her 
research team are exploring the 
cholinergic system, examining in 
detail the enzymes involved and the 
effect of toxic substances on choli-
nergic function. 
"We are conducting basic molecu-
lar pharmacology research on the 
enzymes acetylcholinesterase and 
serum cholinesterase. We're asking 
a number of questions about these 
enzymes: What are the different 
forms of the enzymes? How do they 
work? What will alter their function? 
How does the cholinergic system 
function in general?," Marquis 
explained. 
So far Marquis' study has concen-
trated on isolated model systems 
using calf brain. She also uses a 
form of cholinesterase purified from 
human blood serum in her research. 
Later Marquis will work with organ 
systems in live animals. Such tech-
niques as ultraviolet and fluores-
cence spectrophotometry are used to 
study the properties of the isolated 
proteins and enzymes, and to moni-
tor their interaction with drugs and 
toxic substances. Marquis also tests 
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BUSM researchers near completion 
of 30-year human development study 
the effects of experimental com-
pounds, many of them not yet mar-
keted, on the proteins. 
In addition to determining whether 
there are any serious health effects 
from repeated exposure to very low 
doses of insecticide, the researchers 
aim "to define the mechanisms of 
pesticide toxicity so as to permit the 
development of antidotes ifor these 
substances and also the develop-
ment of newer, safer pesticides with 
greater selectivity," Marquis said. 
Marquis' research to date has 
revealed several previously unidenti-
fied characteristics of organophos-
phates. 
"We have determined that very low 
doses of organophosphate insecti-
cides do alter proteins other than the 
target enzyme acetylcholinesterase 
in the mammalian brain," Marquis 
said. 
Her work also has revealed that a 
purified form of acetylcholinesterase 
can be chemically modified in the 
laboratory to form an enzyme that is 
highly resistant to inhibition by organ-
ophosphates, but is still completely 
functional. "We don't know at this 
point whether such protective modifi-
cation is possible in the natural 
enzyme in mammals," she said. 
Marquis hopes her research will 
shed light on the problem of pesti-
cide disposal. Marquis said that 
organophosphates are not highly 
water-soluble, but still could present 
problems to communities with shal-
low water tables through run-off or 
careless waste disposal. "These pes-
ticides may be getting into our water 
supplies now, and it's a frightening 
situation because we just don't 
understand their low-level, long-term 
health effects," she said. 
—Marilyn J. Davis 
Suggested Further Readings: 
1. Watanabe, A.: Cholinergic Receptor Stimu-
lants, Chapter 5, Basic and Clinical Phar-
macology. Lange, 1982. 
2. Katz, B.: Nerve, Muscle and Synapse. 
McGraw-Hill Co., 1966. 
Scientific studies that span three 
decades are relatively uncommon. 
Studies that examine 30 years of life 
of one group of human subjects, 
beginning at infancy, are even less 
common in the scientific world. At 
Boston University School of Medicine 
such a follow-up study is in its final 
stages. 
The research began three decades 
ago in the months before the sub-
jects were born. Today these sub-
jects are adults working at a full 
range of careers, and the research-
ers at BUSM are looking at them 
once again—attempting to gain an 
overall, long-term perspective of 
human psychological development. 
Among other things, the scientists 
are seeking clues to how early expe-
riences shape the way people act 
and perform in later life: The re-
searchers are asking how an individ-
ual's personality organization at age 
2 can provide the clues for recogniz-
ing that same person at age 25. 
"In a time when so much scientific 
interest has been focused on infancy 
and early childhood developmental 
research, there is an urgent neces-
sity that a broader long-term per-
spective be gained of the early 
developmental process," said Louis 
W. Sander, M.D., a former professor 
of psychiatry at BUSM, who has 
been involved in the study since it 
began. Sander, now a professor of 
psychiatry in the Division of Child 
Psychiatry and Senior Scholar at the 
University of Colorado, hopes that 
this BUSM study will do much to fill 
that need. 
In 1954, a group of BUSM faculty 
members, headed by Eleanor Paven-
stedt, M.D., then chief of the Depart-
ment of Child Psychiatry, began an 
investigation in which they closely 
monitored the lives of 30 children, 
born at University Hospital (then 
called Massachusetts Memorial Hos-
pitals), until their first year of school. 
One pregnant woman was chosen 
each month until the researchers had 
30 subjects. 
"Dr. Pavenstedt's aim was to carry 
out in great detail a longitudinal 
study of early personality develop-
ment," said Sander. "This was based 
on several aspects: first, observation 
of mother-infant interaction; second, 
the repeated examination of infant 
behavior; and finally, the repeated 
gleaning of information from parents 
about the gradual changes in their 
children's behavior and the changes 
in the family." 
So intense was the data collection 
process that the investigators 
actually watched the babies being 
born to record details of the first 
moments of life. They watched the 
infants eat, sleep and cry in their first 
days of life (including a continuous 
eight-hour observation of each child's 
fourth day). 
As the children got older, the 
researchers tested their psychologi-
cal development, watched them play 
and visited them at home. They 
learned about the children's interac-
tion in the life of the family through 
extensive interviews with the moth-
ers. 
The researchers monitored the 
children's development in this 
extremely rigorous manner until the 
children were 3 years old. 
During the children's first year of 
school, the investigators again stud-
ied the youngsters' lives—in class-
room observations, interviews with 
parents and teachers, school rec-
ords, home visits, play sessions and 
psychological testing. 
"In the 1950s, such extensive, 
detailed, systematically collected and 
multileveled data covering the first 
three years of life and over the first 
grade at school was unique. It still 
is," Sander said of the study, which 
was presented at the First World 
Congress of Infant Psychiatry and 
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described in "Frontiers of Infant Psy-
chiatry" (Basic Books, Inc., New 
York, 1983). 
The analysis of the data from the 
original study led Sander to propose 
a model of early childhood develop-
ment that has become widely 
adopted by other investigators over 
the past 20 years. 
The model is based on the idea 
that each stage of the infant's devel-
opment presents an adaptive chal-
lenge to the family system. For 
example, as the baby, primarily 
through its own growth, becomes an 
initiator of plans, activities and social 
contacts, there is a new and different 
demand placed upon the family sys-
tem. 
The new demand is worked out, or 
negotiated, through the many parent-
infant interactions that occur daily. 
The overall pattern of these interac-
tions shape the particular adaptation 
which the baby and the family sys-
tem evoke for that issue. 
Though Pavenstedt's original study 
design did not call for a follow-up 
when the children became older, -
Sander, along with Gerald Stechler, 
Ph.D., a BUSM professor of psychia-
try, and Padraic Burns, M.D., a 
BUSM associate professor of psy-
chiatry, believed a follow-up study 
would be extremely useful because 
of the thoroughness of the original 
data. 
"It is a rarity in the scientific world 
that a sample of infants can be fol-
lowed over 25 years of development 
by the same investigators," said 
Sander. "Development as a process 
does not end at infancy...but there 
has been little opportunity to exam-
ine later aspects in the develop-
mental process when there also is a 
richly-detailed account of the very 
earliest years (of the subjects' lives). 
Here we have such a unique 
chance." 
So in 1979, the researchers began 
the follow-up study. However, there 
were problems to overcome. In the 
25 years since the first project 
began, the "children" had become 
adults; all were in their mid-20s. 
Some had children of their own. 
"We didn't know how to go about 
looking for them. We had old 
addresses, but nothing current. But 
then there was a very simple solu-
tion. Dr. Sander simply went down to 
the Registry of Motor Vehicles and 
immediately found 27 of the 30 fami-
lies. And they were all within a 40-
mile radius of Boston," said Burns. 
Sander, who had developed close 
relationships with some of the fami-
lies over the years, began calling the 
individuals and found them willing to 
be interviewed for a follow-up study. 
The Spencer Foundation and the 
MacArthur Foundation, two private 
philanthropic organizations, donated 
funds for the study and so, 25 years 
after the first subjects were born, the 
project once again was alive. 
The researchers divided into five 
teams working independently of one 
another and their work continues 
today. One group is reviewing the 
data from the observations of the 
subjects' first two years of life—put-
ting together detailed personality pro-
files of each subject as a toddler. A 
second group, the follow-up team, is 
extensively interviewing the subjects 
to learn their life story—how the sub-
jects think they developed and what 
their lives are like now. 
The third team is giving the sub-
jects a wide-range of psychological 
tests aimed at describing their cur-
rent personality characteristics. A 
fourth team is retesting the mothers 
of the subjects with the same tests 
that were administered during their 
pregnancies, and the parents of the 
subjects are the focus of interviews 
being conducted by the fifth team. 
Sander hopes that all the data col-
lection will be concluded by Decem-
ber; then, for the next two years, the 
investigators will analyze the tremen-
dous amount of information. 
"There is a vast number of inter-
esting possibilities of what we can 
learn with this data once it is put 
together," said Burns. 
One of the first aspects of the 
study the researchers will complete 
Padraic Burns, M.D., interviews subject 20 years after stie was first interviewed at age 5 (sfiown 
in inset). (Pfioto by Bradford F. Herzog; inset by Duette Photographiers) 
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when the data is collected is a rec-
ognition test. "We'll end up with a 
profile from the first two years of life 
and try to match that to a similar pro-
file of the current young adult life, to 
see if we can recognize something of 
the adult from child and vice versa," 
said Burns. "Our question is whether 
there is something in the organiza-
tion of behavior in early development 
that is specifically unique and will be 
recognizable in the way the individ-
ual organizes his life later on." 
When this test is complete, the 
team will examine dozens of aspects 
of the lives of the subjects. "One 
obvious but interesting question," 
said Burns, "is this: Is there any con-
nection between their first-grade 
school activity and their young adult 
achievements?" 
In addition, the effects of acciden-
tal happenings on some of the chil-
dren—such as serious illness or 
death of a close relative—will be 
examined. "We will try to find what 
impact these happenings seem to 
have on a child's development," said 
Burns. 
"What has been a problem in 
developmental research is that there 
is a vast amount of data on the first 
couple of years of life. And there 
also is data on later life. But there 
has been very little to connect the 
very early life picture with the adult 
picture in the same individuals," said 
Sander. "We're trying to gain a per-
spective on development that really 
shows what aspects of development 
take place after the first years of life 
and how we can define that longer-
term developmental process." 
—Paul D. Vaskas 
Suggested Further Readings 
1. Sander, L.W.: A 25-year Follow-up of the 
Pavenstedt Longitudinal Research Project, 
Its Relation to Early Intervention. In: Fron-
tiers ot Infant Psychiatry. J.D. Call, E. Gal-
enson, and R.L. Tyson, eds. Basic Books, 
Inc., New York, 1983, p. 225. 
2. Pavenstedt, E.: The Drifters: Children of 
Disorganized Lower-Class Families. Little 
Brown and Co., Boston, Mass., 1967. 
Bypass grafts... 
continued from page 1 
to 30 percent of all grafts in which 
veins are used. For grafts involving 
prosthetic vessels—made either of 
synthetic materials like Dacron, or of 
other kinds of human or animal ves-
sels—the failure rate can exceed 50 
percent. 
Whether the grafts make use of 
veins or prosthetic materials, the rea-
son for such failures is similar. The 
blood vessels with grafts are afflicted 
by a narrowing effect similar to that 
associated with atherosclerosis. 
For vein grafts, this phenomenon 
is known as intimal hyperplasia. For 
prosthetic grafts, it's called anasto-
motic hyperplasia. 
LoGerfo and his associates, in 
related research projects, are seek-
ing ways to prevent hyperplasia in 
both vein and prosthetic grafts. 
"The saphenous vein, which is the 
vein in the leg that is most often 
used in blood-vessel grafts, seldom 
develops clots when it's in its normal 
location," said LoGerfo. "Our view 
has been that if we could preserve 
most or all of the anti-clotting mecha-
nisms in that vein when it's trans-
planted, there would be a good 
chance of achieving better results in 
vein grafts." 
The investigators particularly want 
to protect the endothelium—the inner 
lining of the vessel. The endothelium, 
though but a single cell thick, is 
thought to play a critical role in pre-
venting the events in the blood ves-
sel that are a prelude to hyperplasia. 
One of those events, said LoGerfo, 
is a buildup of blood elements called 
platelets along the vessel wall. "We 
think that the aggregation of platelets 
along the vessel wall is the first step 
in intimal hyperplasia. One of the 
main reasons we think so is the fact 
that platelets produce a substance, 
called platelet-derived growth factor, 
that causes the smooth muscle cells 
in the vessel wall to proliferate." 
This proliferation, in turn, leads to 
Frank W. LoGerfo, M.D., rig fit, discusses 
studies in tine Vascular Dynamics Laboratory 
with research technician Paul Andrew, left. 
(Photo by Educational Media, BUSM) 
the vessel shrinkage that is the hall-
mark of hyperplasia, he added. 
Knowing that any blood vessel's 
reaction to trauma is a sharp con-
striction, the investigators decided 
that one way to protect the endothe-
lium might be to head off that reac-
tion before the vein was removed. 
The technique chosen, said 
LoGerfo, was to inject a muscle-
relaxant called papaverine into the 
area around the vein before the ves-
sel was removed. This method was 
devised in collaboration with Christian 
0. Haudenschild, M.D., BUSM asso-
ciate professor of pathology, a spe-
cialist in blood vessel injury and 
repair at Boston City Hospital. 
This approach, tested first in labo-
ratory animals, had the desired 
effect. Examination of the endothe-
lium from the pretreated veins 
showed none of the rips and malfor-
mations found in the cells lining 
untreated veins. 
The investigators, again using lab-
oratory animals, then showed that 
the technique could help prevent 
delayed failures of vein grafts. 
The approach, said LoGerfo, 
seemed promising enough to be tried 
with patients. The investigator, who 
is also a vascular surgeon, said that 
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in the 28 patients on whom it has 
been used, the results have been 
excellent—only two delayed failures 
have occurred. 
LoGerfo emphasized that his use 
of papaverine-treated veins did not 
constitute a controlled clinical trial, 
since there was no comparable 
group of patients with whom tradi-
tional procedures were used. He 
added, though, that the better than 
90 percent success rate achieved 
has sparked considerable interest in 
the technique. 
In their work with prosthetic grafts, 
LoGerfo's group has been trying to 
solve one of the most nettlesome 
problems associated with such 
grafts—the high failure rate in 
smaller arteries. 
"In large blood vessels, like the 
aorta, grafts using materials such as 
Dacron work very well," explained 
LoGerfo. "But once you get down 
below a certain size—it appears to 
be around 8 millimeters or so—the 
problem of hyperplasia becomes 
severe enough to cause a very high 
rate of late failures." 
Investigating the reasons for such 
failures, the surgeon and his associ-
ates found the narrowing always 
occurs at the downstream end of the 
graft. 
"One obvious possibility," said the 
surgeon, "is that the platelets are 
stimulated by contact with the inner 
lining of the graft, but can't do any-
thing about it until they get to the 
smooth-muscle cells in the artery 
that the graft is hooked up to." 
To test this hypothesis, the investi-
gators have embarked on a joint 
research venture with C. Robert Val-
eri, M.D., a professor of medicine 
and director of the BUSM-based U.S. 
Naval Blood Research Laboratory; 
and Bernard E. Statland, M.D., 
Ph.D., a professor of medicine and 
pathology at BUSM and director of 
laboratory medicine at University 
Hospital. 
The project, said LoGerfo, involves 
studies of blood from patients with 
kidney failure, whose blood must be 
purified by artificial means. 
Samples of the blood before it 
enters the tubes leading to the 
dialysis, or purifying, device are com-
pared with samples of blood that has 
been through the tubes. The aim, 
said the surgeon, is to identify 
changes in the blood that result from 
its contact with the artifical surface. 
Although the work is in its early 
stages, LoGerfo said the preliminary 
results suggest that the investigators 
are likely to succeed in identifying 
the blood changes linked to passage 
through the tubes. If they do, the 
project may shed light on what 
accounts for late failures in prosthetic 
grafts. At the same time, by provid-
ing benchmarks to use in assessing 
potentially harmful changes in blood 
that passes through synthetic materi-
als, it may offer an effective new 
technique for evaluating different 
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materials for their usefulness in pros-
thetic grafts. 
"If we can identify a good way to 
evaluate one synthetic material as 
opposed to another (for use as a 
graft), it would be a big step for-
ward," said LoGerfo. "We might be 
able to develop new kinds of pros-
thetic grafts that avoid this high fail-
ure rate. In fact, we've already initi-
ated an effort to improve the surface 
of Dacron grafts in collaboration with 
Dr. Carl Franzblau." (Carl Franzblau, 
Ph.D., is professor and chairman of 
the Department of Biochemistry at 
BUSM.) 
"This would mean a greatly 
improved outlook for patients who 
get prosthetic grafts in small-artery 
bypass operations," said LoGerfo. "It 
also would mean that we could sub-
stitute prosthetic grafts for vein grafts 
much more often, and avoid all the 
trouble and time that's involved in 
transplanting a vein." 
—Richard P. Anthony 
Suggested Further Readings 
1. LoGerfo F.W. et al: Downstream anasto-
motic hyperplasia: A mechanism of failure 
in Dacron arterial grafts. Ann Surg. 197: 
479, 1983. 
2. Sharefkin J.B. et. al.: Early normalization of 
platelet survival time by endothelial seeding 
of Dacron arterial prostheses in dogs. Sur-
gery 92: 385, 1982. 
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